These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9675670)

  • 1. Fasting hyperglycaemia following trans-catheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis.
    Lonardo A
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):236. PubMed ID: 9675670
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is there a place for arterial chemoembolization of the liver in the treatment for hepatocellular carcinoma?].
    Trinchet JC; Mathieu D; Beaugrand M
    Gastroenterol Clin Biol; 1995 Dec; 19(12):967-9. PubMed ID: 8729406
    [No Abstract]   [Full Text] [Related]  

  • 3. Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis.
    Farinati F; Rinaldi M; Del Prato S; Lana S; De Maria N; Paleari D; Marafin C; Naccarato R
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):427-33. PubMed ID: 9494852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatocellular carcinoma complicating cirrhosis. Therapeutic possibilities].
    Porcheron J; Cadi F; Tardieu D; Balique JG
    Ann Gastroenterol Hepatol (Paris); 1992; 28(3):131-9. PubMed ID: 1325136
    [No Abstract]   [Full Text] [Related]  

  • 5. [Continuing education. Treatment of hepatocellular carcinoma in cirrhosis. Introduction].
    Castaing D
    Ann Chir; 1998; 52(6):509-10. PubMed ID: 9752499
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemoembolization techniques for hepatocellular carcinoma in cirrhosis].
    Vetter D; Bronowicki JP; Doffoël M
    Ann Chir; 1998; 52(6):527-34. PubMed ID: 9752502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The analysis of superselective catheterization technique; transcatheter segmental arterial embolization using lipiodol for hepatocellular carcinoma].
    Satoh O; Uchida H; Nishimine K; Yoshioka T; Ohishi H; Tsushima J; Ohue S; Matsuo N
    Rinsho Hoshasen; 1990 Jun; 35(6):685-90. PubMed ID: 2167398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of hepatocellular carcinoma treated with specific substance of Maruyama resulting in a partial response].
    Mizuno T; Ikezoe T; Kotani K; Yoshihara T; Sanada T; Yamaguchi D; Ota M; Goto Y; Okuda Y; Horimoto M; Suzuki K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1862-4. PubMed ID: 24393947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date.
    Tsochatzis E; Meyer T; Marelli L; Burroughs AK
    J Hepatol; 2010 Sep; 53(3):588. PubMed ID: 20472319
    [No Abstract]   [Full Text] [Related]  

  • 10. [High insulin requirements after chemoembolization of hepatocarcinoma].
    Smith HF; Belletti GA; Yorio MA
    Medicina (B Aires); 2007; 67(2):218-9. PubMed ID: 17593614
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
    Brown DB; Cardella JF; Sacks D; Goldberg SN; Gervais DA; Rajan D; Vedantham S; Miller DL; Brountzos EN; Grassi CJ; Towbin RB
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):225-32. PubMed ID: 16517768
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of 5F superflexible catheter for hepatic arterial embolization].
    Nakagawa K; Nakano T; Matsui H; Hamada T; Ishida O
    Rinsho Hoshasen; 1989 Aug; 34(8):929-31. PubMed ID: 2555598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The change of plasma glucose after the embolization of hepatic arteries.
    Yoshida M; Ishida S; Izumi K; Nakata Y; Morimoto K; Miyata T; Sai H; Hashimoto M; Hara K; Kido T
    Med J Osaka Univ; 1985 Sep; 36(1-2):1-4. PubMed ID: 3022118
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cisplatin dose intensity on response and survival for patients with unresectable and untransplantable hepatocellular carcinoma: an analysis of 57 patients.
    Carr BI; Dvorchik I
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():432-5. PubMed ID: 10895191
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease.
    Yoshimi A; Yamamoto G; Goto T; Koike K; Kurokawa M
    Ann Hematol; 2012 Sep; 91(9):1501-2. PubMed ID: 22314841
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hepatocellular carcinoma in cirrhosis: locoregional therapies for bridging to liver transplant.
    Lee FT
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S24-6. PubMed ID: 17969066
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization for hepatocellular carcinoma.
    Lau WY; Yu SC; Lai EC; Leung TW
    J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocellular carcinoma.
    Ahn J; Flamm SL
    Dis Mon; 2004 Oct; 50(10):556-73. PubMed ID: 15616490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.